arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

RadNet, Inc.

RDNT
$78.08 ▼ -2.22 (-2.76%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Neutral
auto_awesome

Analytical Summary

RadNet, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $6.1B
Dividend Yield —
Revenue Growth 25.0% ↗
Op. Margin 6.3% ↗
ROIC 1.2% ↗
FCF / Share $1.21 ↗
Trailing P/E 780.8x
Price / Book 5.6x
FCF Yield 1.6%
Debt / Equity 1.22
info Valuation on last close. End-of-day price, Nov 5, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$622.72M
↑ +25.0% —
Net Income Profit after all expenses
$7.53M
↓ -47.9% —
Operating Margin Operating profit as % of sales
6.3%
↑ +252.6% 37th
FCF / Share Free cash flow per share
$1.21
↑ +18.0% —
Long-Term Debt Long-term obligations
$1.33B
↑ +22.6% —

Health Breakdown

Profitability →
46
Returns
42
Financial Health ↓
41
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 67 quarters